Chai Jing, Jia Lijie, Cao Huimin, Zhang Xiaoyu, Xu Zifeng
Department of Anesthesiology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China.
Ann Transl Med. 2020 Dec;8(23):1584. doi: 10.21037/atm-20-1724.
Evidence showed that the use of epidural analgesia increased the risk of maternal fever during labor, and the potential mechanisms involved inflammation. Lymphocyte played a role in the inflammatory responses, and lymphopenia predicted adverse outcomes for patients. The aim of this study was to investigate whether lymphocyte count was associated with the incidence of intrapartum fever in nulliparous women undergoing vaginal delivery.
In this retrospective cohort study, electronic medical record data at the International Peace Maternity and Child Health Hospital (IPMCH, Shanghai, China) between 2012 and 2017 were extracted. The primary outcome of this study was baseline lymphocyte count in febrile and afebrile parturients who received labor epidural analgesia. Other confounding factors associated with the development of intrapartum fever were analyzed using multivariable logistic regression.
The final study population consisted of 36,562 parturients, of whom 18,952 (51.8%) received labor epidural analgesia. Labor epidural analgesia was associated with an increased risk of maternal fever [relative risk: 4.55; 95% confidence interval (CI): 4.16-4.98; P<0.001]. Among the parturients who received epidural analgesia, both baseline lymphocyte count and lymphocyte percentage were lower in the febrile patients than those in the afebrile patients (P<0.001; P=0.015). The lower (<1.1×10/L) baseline lymphocyte was associated with a higher risk of maternal fever (adjusted odds ratio: 1.30, 95% CI: 1.14-1.48; P<0.001).
Our results suggested that lower lymphocyte baseline indicated an increased risk of maternal fever during epidural analgesia-involved labor. Further studies are needed to confirm the findings and determine the potential mechanisms.
有证据表明,分娩期间使用硬膜外镇痛会增加产妇发热的风险,其潜在机制涉及炎症反应。淋巴细胞在炎症反应中发挥作用,淋巴细胞减少预示着患者预后不良。本研究的目的是调查淋巴细胞计数是否与经阴道分娩的初产妇产时发热的发生率相关。
在这项回顾性队列研究中,提取了2012年至2017年期间上海国际和平妇幼保健院的电子病历数据。本研究的主要结局是接受分娩硬膜外镇痛的发热和未发热产妇的基线淋巴细胞计数。使用多变量逻辑回归分析与产时发热发生相关的其他混杂因素。
最终的研究人群包括36562名产妇,其中18952名(51.8%)接受了分娩硬膜外镇痛。分娩硬膜外镇痛与产妇发热风险增加相关[相对风险:4.55;95%置信区间(CI):4.16-4.98;P<0.001]。在接受硬膜外镇痛的产妇中,发热患者的基线淋巴细胞计数和淋巴细胞百分比均低于未发热患者(P<0.001;P=0.015)。较低的(<1.1×10⁹/L)基线淋巴细胞计数与产妇发热风险较高相关(调整后的优势比:1.30,95%CI:1.14-1.48;P<0.001)。
我们的结果表明,较低的淋巴细胞基线表明在硬膜外镇痛分娩期间产妇发热风险增加。需要进一步的研究来证实这些发现并确定潜在机制。